Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

13.42
Delayed Data
As of Apr 24
 -0.25 / -1.83%
Today’s Change
4.13
Today|||52-Week Range
13.77
+18.76%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Mulroy Robert J
President & Chief Executive Officer
Sale12/05/2014175,000$9.85$1.7M+38.49%
Mulroy Robert J
President & Chief Executive Officer
Sale2/20/2015150,000$10.94$1.6M+21.89%
Mulroy Robert J
President & Chief Executive Officer
Sale3/24/2015103,968$11.71$1.2M+16.29%
Nielsen Ulrik B
Chief Scientific Officer & Senior Vice President
Sale5/27/2014105,000$8.01$841.1K+67.75%
Sullivan William A
Chief Financial Officer & Treasurer
Sale9/29/201464,404$8.40$541.0K+59.38%
Nielsen Ulrik B
Director
Sale4/20/201540,000$12.88$515.2K+5.59%
Nielsen Ulrik B
Director
Sale3/19/201540,000$11.97$478.8K+11.09%
Mulroy Robert J
President & Chief Executive Officer
Buy3/24/2015273,968$1.71$468.5K+16.29%
Sullivan William A
Chief Financial Officer & Treasurer
Sale9/30/201440,878$8.94$365.4K+52.85%
Mulroy Robert J
President & Chief Executive Officer
Buy8/21/2014280,168$1.25$350.2K+110.68%
Page of 13

To view my watchlist

Not a member yet?

Sign up now for a free account